Primary Record
Triclabendazole
- In stock
- 1,459 g
- Purity
- 98.1 %
- CAS
- 68786-66-3
Compound Identifiers & Properties
- CAS
- 68786-66-3
- PubChem CID
- 50248
- SMILES
- CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl
- Canonical SMILES
- CSc1nc2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2[nH]1
Names & Synonyms
- Triclabendazole
- Fasinex
- 68786-66-3
- Triclabendazol
- Egaten
- Triclabendazolum
- Fasicare
- Tremacide
- Flukare
- Egaten tm
- Triclabendazole CRS
- Fasinex (TN)
- C14H9Cl3N2OS
- Egaten (TN)
- NVP-EGA230
- EGA230B
- RefChem:58513
- Triclabendazol [INN-Spanish]
- Triclabendazolum [INN-Latin]
- DTXSID7043952
- 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo[d]imidazole
- Triclabendazole [BAN:INN]
- Triclabendazole Micronized
- CCRIS 8988
- Triclabendazole (Standard)
- D02VMJ
- CGA-89317, Egaten
- MLS001424101
- NQPDXQQQCQDHHW-UHFFFAOYSA-N
- Triclabendazole [INN:BAN]
- TRICLABENDAZOLE [MI]
- Oprea1_236106
- Triclabendazole (USAN/INN)
- CHEMBL1086440
- DTXCID5023952
- TRICLABENDAZOLE [INN]
- UNII-4784C8E03O
- cid_50248
- MLS000759473
- MLS000876812
- NSC-759250
- SCHEMBL165712
- TRICLABENDAZOLE [USAN]
- CGA 89317
- MFCD00864519
- AC1L18Q8
- BEN631
- orb1310247
- orb3024998
- SCHEMBL3499260
- TRICLABENDAZOLE [MART.]
- 4784C8E03O
- SCHEMBL29394758
- SCHEMBL29409229
- TRICLABENDAZOLE [WHO-DD]
- BDBM58491
- CHEBI:94759
- CTK5C8452
- HY-B0621R
- KS-00000KPE
- MSK5581
- P02BX04
- CGA-89317
- Triclabendazole [USAN:INN:BAN]
- C14-H9-Cl3-N2-O-S
- CPD000466357
- HMS2051E16
- HMS2232D14
- HMS3370H02
- HMS3393E16
- HMS3652M16
- HMS3715P16
- HMS3744I09
- HMS5082G16
- KUC103451N
- Pharmakon1600-01505786
- CGA89317
- CID50248
- HY-B0621
- ZINC1444556
- 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole
- Tox21_112231
- ANW-42745
- CID:50248
- EBC-26788
- EBC-84235
- MFCD03147039
- MSK5581-100A
- MSK5581-100M
- NCGC00164610-01
- NSC759250
- s4114
- STK332284
- TRICLABENDAZOLE [ORANGE BOOK]
- SMR000466357
- Triclabendazole for system suitability
- Triclabendazole, 98% - 10G 10g
- 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole
- AKOS005439340
- AKOS015950804
- MSK5581-1000M
- AC-7627
- AN-8843
- AT10531
- CCG-100881
- CCG-268150
- CS-2859
- CS-W-00074
- DB12245
- FT28419
- KS-5329
- MP-0274
- NC00131
- NSC 759250
- SB17173
- NCGC00164610-02
- NCGC00164610-08
- 6-Chloro-5- -2-methylthio-benzimidazole
- AJ-26174
- AK-68238
- BR-68238
- CJ-23547
- CJ-23548
- I018
- LS-32758
- SAM001246681
- SC-17720
- Triclabendazole 100 microg/mL in Acetonitrile
- 6-Chloro-5-(2,3-dichlorophenoxy)-2-methylthio-benzimidazole
- SBI-0207022.P001
- SID:376229570
- Triclabendazole for system suitability CRS
- 1H-Benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-
- AB0013427
- AB1004580
- CAS-68786-66-3
- J126.317J
- ST2418930
- TL8004821
- TR-022940
- B1860
- FT-0602564
- NS00000576
- SW197511-2
- T2826
- 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole
- D07364
- Triclabendazole Solution in Methanol, 100ug/mL
- 5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLSULFANYL)-1H-1,3-BENZODIAZOLE
- 6-chloro-5-(2,3-dichlorophenoxy)-2-methylthiobenzimidazole
- AB00639964-10
- AB00639964_12
- AB00639964_13
- Triclabendazole Solution in Methanol, 1000ug/mL
- 786T663
- A836250
- C039276
- F079305
- Q419739
- SR-01000759363
- I06-0122
- SR-01000759363-4
- Triclabendazole Solution in Acetonitrile, 100ug/mL
- Triclabendazole, VETRANAL(TM), analytical standard
- 5-Chloro-6-(2,3-dichlorophenoxy)-2-methylthiobenzimidazole
- BRD-K81916719-001-05-5
- BRD-K81916719-001-13-9
- BRD-K81916719-001-14-7
- 1H-BENZIMIDAZOLE, 5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLTHIO)-
- D000077682
- Z3069281092
- 5-chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo[d]imidazole
- 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole
- A3375/0143230
- 6-[2,3-bis(chloranyl)phenoxy]-5-chloranyl-2-methylsulfanyl-1H-benzimidazole
- 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-1,3-benzodiazole
- 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole
- 6-CHLORO-5-(2,3-DICHLOROPHENOXY)-2-METHYLTHIO-BENZ
- Triclabendazole, EuropePharmacopoeia (EP) Reference Standard
- 5-Chloro-6-(2',3'-dichlorophenoxy)-2-(methylthio)benzimidazole
- 5-chloro-6-(2,3-dichlorophenoxy)-2-methylthio-1h-benzimidazole
- 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio) -1H-benzimidazole
- 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-1,3-benzimidazole
- 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-benzimidazole
- 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-benzimidazole
- 5-[2,3-bis(chloranyl)phenoxy]-6-chloranyl-2-methylsulfanyl-1H-benzimidazole
- 6-CHLORO-2-(METHYLSULFANYL)-1H-1,3-BENZIMIDAZOL-5-YL (2,3-DICHLOROPHENYL) ETHER
- Triclabendazole for system suitability, EuropePharmacopoeia (EP) Reference Standard
- 614-728-7
- JA9